Banyan Capital Management Inc. lowered its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC – Free Report) by 19.4% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 102,722 shares of the company’s stock after selling 24,712 shares during the period. Henry Schein accounts for approximately 4.3% of Banyan Capital Management Inc.’s holdings, making the stock its 12th largest position. Banyan Capital Management Inc.’s holdings in Henry Schein were worth $7,108,000 at the end of the most recent quarter.
A number of other institutional investors have also recently bought and sold shares of the business. Sumitomo Mitsui DS Asset Management Company Ltd increased its holdings in shares of Henry Schein by 2.7% in the third quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 12,994 shares of the company’s stock valued at $947,000 after purchasing an additional 340 shares during the last quarter. Blue Trust Inc. boosted its holdings in shares of Henry Schein by 157.0% during the 3rd quarter. Blue Trust Inc. now owns 2,393 shares of the company’s stock worth $174,000 after buying an additional 1,462 shares during the period. Tempus Wealth Planning LLC grew its stake in Henry Schein by 16.1% in the 3rd quarter. Tempus Wealth Planning LLC now owns 5,348 shares of the company’s stock valued at $390,000 after buying an additional 741 shares during the last quarter. Assenagon Asset Management S.A. raised its holdings in Henry Schein by 772.1% in the 3rd quarter. Assenagon Asset Management S.A. now owns 254,580 shares of the company’s stock valued at $18,559,000 after acquiring an additional 225,388 shares during the period. Finally, Cromwell Holdings LLC lifted its position in Henry Schein by 93.4% during the third quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock worth $26,000 after acquiring an additional 170 shares during the last quarter. Institutional investors and hedge funds own 96.62% of the company’s stock.
Henry Schein Trading Up 0.3 %
Shares of HSIC stock opened at $77.83 on Thursday. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. Henry Schein, Inc. has a fifty-two week low of $63.67 and a fifty-two week high of $82.63. The company has a market cap of $9.70 billion, a PE ratio of 32.03, a P/E/G ratio of 2.15 and a beta of 0.91. The stock’s fifty day moving average price is $74.11 and its two-hundred day moving average price is $72.11.
Wall Street Analysts Forecast Growth
View Our Latest Analysis on HSIC
Henry Schein Company Profile
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Further Reading
- Five stocks we like better than Henry Schein
- Quiet Period Expirations Explained
- Nebius Group: NVIDIA’s Investment Sparks All-Time Highs
- Learn Technical Analysis Skills to Master the Stock Market
- SoFi Stock Rallying Strong in the Last 5 Days—What’s Driving It?
- Health Care Stocks Explained: Why You Might Want to Invest
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC – Free Report).
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.